BioCryst agreed to acquire Astria in a cash and stock deal with an equity value of $920 million and an enterprise value of $700 million. BioCryst will acquire each Astria share for $8.55 in cash and 0 ...

A heart attack occurs when the blood flow that brings oxygen to the heart is reduced or cut off. If blood flow is reduced or ...

FMC-242 is a potentially best-in-class covalent allosteric inhibitor that breaks the interaction between PI3Kα and RAS, ...